A review of systemic infiltrative diseases and associated endocrine diseases

Sharma, 1994, Sarcoidosis: diagnosis, staging, and the role of newer diagnostic modalities, Clin Pulm Med., 1, 18, 10.1097/00045413-199401000-00004 Ungprasert, 2016, Epidemiology of sarcoidosis 1946-2013: a population-based study, Mayo Clin Proc., 91, 183, 10.1016/j.mayocp.2015.10.024 Porter, 2003, Endocrine and reproductive manifestations of sarcoidosis, QJM - Mon J Assoc Physicians., 96, 553, 10.1093/qjmed/hcg103 DeRemee, 1985, Serum angiotensin-converting enzyme activity: its use in the evaluation and management of hypercalcemia associated with sarcoidosis, Arch Intern Med., 145, 677, 10.1001/archinte.1985.00360040099022 Sharma, 1996, Vitamin D, calcium, and sarcoidosis, Chest., 109, 535, 10.1378/chest.109.2.535 Tomita, 1995, [Primary hyperparathyroidism associated with sarcoidosis], Nihon Rinsho., 53, 949 Sinha, 1997, Long-term management of hypercalcaemia in chronically active sarcoidosis, J R Soc Med., 90, 156, 10.1177/014107689709000311 Conron, 2000, Calcium metabolism in sarcoidosis and its clinical implications, Rheumatology., 39, 707, 10.1093/rheumatology/39.7.707 Stern, 1985, Sarcoidosis and its neurological manifestations, Arch Neurol., 42, 909, 10.1001/archneur.1985.04060080095022 Pekic, 2017, Diagnosis of endocrine disease: expanding the cause of hypopituitarism, Eur J Endocrinol., 176, R269, 10.1530/EJE-16-1065 Anthony, 2016, Hypothalamic-pituitary sarcoidosis with vision loss and hypopituitarism: case series and literature review, Pituitary., 19, 19, 10.1007/s11102-015-0678-x Randeva, 2002, Isolated neurosarcoidosis—a diagnostic enigma: case report and discussion, Endocrine., 17, 241, 10.1385/ENDO:17:3:241 Mayock, 1963, Manifestations of sarcoidosis: analysis of 145 patients, with a review of nine series selected from the literature, Am J Med., 35, 67, 10.1016/0002-9343(63)90165-7 Papadopoulos, 1996, High frequency of endocrine autoimmunity in patients with sarcoidosis, Eur J Endocrinol., 134, 331, 10.1530/eje.0.1340331 Okuma, 2017, Systemic sarcoidosis with thyroid involvement, Intern Med., 56, 2181, 10.2169/internalmedicine.8324-16 Vesely, 1977, Partial hypopituitarism and possible hypothalamic involvement in sarcoidosis. Report of a case and review of the literature, Am J Med., 62, 425, 10.1016/0002-9343(77)90842-7 Karlish, 1970, Sarcoidosis, thyroiditis, and Addison’s disease, Lancet., 296, 330, 10.1016/S0140-6736(70)92871-0 Turk, 1986, Diagnosis and management of testicular sarcoidosis, J Urol., 135, 380, 10.1016/S0022-5347(17)45648-5 Metcalfe, 1998, Sarcoidosis presenting as a testicular mass, Br J Urol., 82, 769, 10.1046/j.1464-410X.1998.00776.x DiCarlo Jr, 1989, R: sporadic reports of sarcoidosis involving the uterus have been, Arch Pathol Lab Med., 113, 941 Willman, 1994, Langerhans’-cell histiocytosis (Histiocytosis X)—a clonal proliferative disease, N Engl J Med., 331, 154, 10.1056/NEJM199407213310303 Dunger, 1989, The frequency and natural history of diabetes insipidus in children with Langerhans-cell histiocytosis, N Engl J Med., 321, 1157, 10.1056/NEJM198910263211704 Munir, 2012, Langerhans cell histiocytosis: a multisystem disorder, J R Coll Physicians Edinb., 42, 311, 10.4997/JRCPE.2012.406 Kaltsas, 2000, Hypothalamo-pituitary abnormalities in adult patients with Langerhans cell histiocytosis: clinical, endocrinological, and radiological features and response to treatment, J Clin Endocrinol Metab., 85, 1370, 10.1210/jcem.85.4.6501 Prosch, 2004, Central diabetes insipidus as presenting symptom of Langerhans cell histiocytosis, Pediatr Blood Cancer., 43, 594, 10.1002/pbc.20102 Donadieu, 2004, Endocrine involvement in pediatric-onset Langerhans’ cell histiocytosis: a population-based study, J Pediatr., 144, 344, 10.1016/j.jpeds.2003.12.030 Crois, 2006, Risk factors for diabetes insipidus in Langerhans cell histiocytosis, Pediatr Blood Cancer., 46, 228, 10.1002/pbc.20425 Grois, 2004, Course and clinical impact of magnetic resonance imaging findings in diabetes insipidus associated with Langerhans cell histiocytosis, Pediatr Blood Cancer., 43, 59, 10.1002/pbc.20003 Bhargava, 2012, Hand-Schüller-Christian disease, Indian J Dent Res., 23, 830, 10.4103/0970-9290.111273 Kitahama, 1996, Thyroid involvement by malignant histiocytosis of Langerhans’ cell type, Clin Endocrinol (Oxf)., 45, 357, 10.1046/j.1365-2265.1996.8020819.x Behrens, 2001, Langerhans cell histiocytosis of the thyroid: a report of two cases and review of the literature, Thyroid., 11, 697, 10.1089/105072501750362781 Adams, 2007, Haemochromatosis, Lancet., 370, 1855, 10.1016/S0140-6736(07)61782-6 Olynyk, 2008, Hereditary hemochromatosis in the post-HFE era, Hepatology., 48, 991, 10.1002/hep.22507 Capell, 2004, Case study: hemachromatosis in type 2 diabetes, Clin Diabetes., 22, 101, 10.2337/diaclin.22.2.101 McClain, 2006, High prevalence of abnormal glucose homeostasis secondary to decreased insulin secretion in individuals with hereditary haemochromatosis, Diabetologia., 49, 1661, 10.1007/s00125-006-0200-0 Pelusi, 2016, Endocrine dysfunction in hereditary hemochromatosis, J Endocrinol Invest., 39, 837, 10.1007/s40618-016-0451-7 Ellervik, 2001, Prevalence of hereditary haemochromatosis in late-onset type 1 diabetes mellitus: a retrospective study, Lancet., 358, 1405, 10.1016/S0140-6736(01)06526-6 Hatunic, 2010, Glucose metabolism after normalization of markers of iron overload by venesection in subjects with hereditary hemochromatosis, Metabolism., 59, 1811, 10.1016/j.metabol.2010.06.005 Bergeron, 1978, Pituitary siderosis. A histologic, immunocytologic, and ultrastructural study, Am J Pathol., 93, 295 McNeil, 1983, The endocrine manifestations of hemochromatosis, Am J Med Sci., 285, 7, 10.1097/00000441-198305000-00002 McDermott, 2005, Extensive clinical experience: hypogonadism in hereditary hemochromatosis, J Clin Endocrinol Metab., 90, 2451, 10.1210/jc.2004-0980 Kelly, 1984, Hypogonadism in hemochromatosis: reversal with iron depletion, Ann Intern Med., 101, 629, 10.7326/0003-4819-101-5-629 Hempenius, 1999, Mineralocorticoid status and endocrine dysfunction in severe hemochromatosis, J Endocrinol Invest., 22, 369, 10.1007/BF03343575 Guggenbuhl, 2005, Bone mineral density in men with genetic hemochromatosis and HFE gene mutation, Osteoporos Int., 16, 1809, 10.1007/s00198-005-1934-0 Valenti, 2009, Association between iron overload and osteoporosis in patients with hereditary hemochromatosis, Osteoporos Int., 20, 549, 10.1007/s00198-008-0701-4 Yamasaki, 2009, Excess iron inhibits osteoblast metabolism, Toxicol Lett., 191, 211, 10.1016/j.toxlet.2009.08.023 Merlini, 2003, Molecular mechanisms of amyloidosis, N Engl J Med., 349, 583, 10.1056/NEJMra023144 Sunde, 1997, Common core structure of amyloid fibrils by synchrotron X-ray diffraction, J Mol Biol., 273, 729, 10.1006/jmbi.1997.1348 Ozdemir, 2010, Endocrine involvement in system amyloidosis, Endocr Pract., 16, 1056, 10.4158/EP10095.RA Kyle, 1995, Primary systemic amyloidosis: clinical and laboratory features in 474 cases, Semin Hematol., 32, 45 Röcken, 2002, Pathology, diagnosis and pathogenesis of AA amyloidosis, Virchows Arch., 440, 111, 10.1007/s00428-001-0582-9 Benson, 2003, The hereditary amyloidoses, Best Pract Res Clin Rheumatol., 17, 909, 10.1016/j.berh.2003.09.001 Verbeke, 2018, Anterior hypopituitarism in a patient with amyloidosis secondary to Crohn’s disease: a case report, J Med Case Rep., 12, 10, 10.1186/s13256-018-1719-7 Ozdemir, 2011, Amyloid goiter and hypopituitarism in a patient with systemic amyloidosis, Amyloid., 18, 32, 10.3109/13506129.2010.545961 Röcken, 1995, Interstitial amyloid deposits in the pituitary gland: morphometry, immunohistology, and correlation to diseases, Arch Pathol Lab Med., 119, 1055 Saitoh, 1985, Accumulation of amyloid in pituitary adenomas, Acta Neuropathol., 68, 87, 10.1007/BF00688628 Villa, 2008, Amyloid goiter, Int J Surg., 6, S16, 10.1016/j.ijsu.2008.12.025 D’Antonio, 2000, Amyloid goiter: the first evidence in secondary amyloidosis. Report of five cases and review of literature, Adv Clin Path., 4, 99 El-Reshaid, 1994, Amyloidosis of the thyroid gland: role of ultrasonography, J Clin Ultrasound., 22, 239, 10.1002/jcu.1870220405 Kavukçu, 1997, Renal, gastric and thyroidal amyloidosis due to familial Mediterranean fever, Pediatr Nephrol., 11, 210, 10.1007/s004670050263 Hatabu, 1990, Amyloid goiter: radiologic findings, Am J Roentgenol., 155, 193, 10.2214/ajr.155.1.2112846 Ertürk, 1995, Amyloid deposition in the thyroid gland in patients with amyloidosis: an incidence study with fine-needle aspiration biopsy of the thyroid, Nephrol Dial Transplant., 10, 1473 Yaeger, 2010, Amyloid goiter, Diagn Cytopathol., 38, 742 Keven, 2001, Polyglandular endocrine failure in a patient with amyloidosis secondary to familial Mediterranean fever, Am J Kidney Dis., 38, 1, 10.1053/ajkd.2001.29295 Arik, 1990, Subclinical adrenocortical insufficiency in renal amyloidosis, Nephron., 56, 246, 10.1159/000186148 Danby, 1990, Adrenal dysfunction in patients with renal amyloid, QJM An Int J Med., 76, 915 Troussard, 1989, Massive systemic amyloidosis associated with light-chain deposition disease, Nephron., 52, 139, 10.1159/000185616 Handelsman, 1983, Hypogonadism and massive testicular infiltration due to amyloidosis, J Urol., 129, 610, 10.1016/S0022-5347(17)52258-2 Özdemir, 2002, Value of testis biopsy in the diagnosis of systemic amyloidosis, Urology., 59, 201, 10.1016/S0090-4295(01)01510-2